Table 3.
Hazard ratio of RVO in ESRD group and KT group.
| Outcomes | Groups | Rate | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|---|---|
| Per 1000 patient-years | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | ||
| RVO, total | ESRD | 5.68 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) | |||
| KT | 2.74 | 0.49 (0.40, 0.59) | < 0.001 | 0.48 (0.40, 0.58) | < 0.001 | 0.47 (0.29, 0.58) | < 0.001 | |
| Non-ischemic RVO | ESRD | 4.60 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) | |||
| KT | 2.26 | 0.50 (0.4, 0.61) | < 0.001 | 0.49 (0.39, 0.60) | < 0.001 | 0.48 (0.39, 0.60) | < 0.001 | |
| Ischemic RVO | ESRD | 1.07 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) | |||
| KT | 0.48 | 0.46 (0.30, 0.72) | < 0.001 | 0.45 (0.29, 0.70) | < 0.001 | 0.44 (0.28, 0.70) | < 0.001 | |
Analysis was performed using Cox regression. Model 1: not adjusted; Model 2: adjusted with age, sex; Model 3: adjusted with age, sex, diabetes mellitus, hypertension, dyslipidemia, Charlson comorbidity index, income status.
CI confidence interval, ESRD end stage renal disease, KT kidney transplantation, RVO renal vein occlusion.